Companies: 10,795·Total market cap: $144.5T
Connect Biopharma Holdings Limited

Connect Biopharma Holdings Limited

CNTBNASDAQHealthcare● Active
$2.20
+$0.03(+1.38%)
Market Cap$138520477
P/E Ratio—
52W High$3.82
52W Low$0.77
Overview
Foreign Private Issuer · Files 20-F / 6-K

Connect Biopharma Holdings Limited (CNTB) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001835268 · CNTB · NASDAQ · as of Jun 9, 2026

Filing snapshot

182
Total Filings
4
Latest Form
2026-06-02
Most Recent
2021
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001835268 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-31
Fiscal Year End
Mar 31, 2026
Accession No.
0001835268-26-000013
Primary Document
cntb-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001835268 · Accession 0001835268-26-000013

Latest Key Filings

6-KQuarterly Report
6-K
2025-03-28
View 6-K on SEC
8-KCurrent Report
8-K
2026-05-12Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
EFFECTEFFECT
EFFECT
2026-06-01
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
F-3F-3
F-3
2026-05-15
View
10-QQuarterly Report
10-Q
2026-05-12
View
8-KCurrent Report
8-K
2026-05-12
View
8-KCurrent Report
8-K
2026-04-23
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-04-14
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-04-01
View
10-KAnnual Report
10-K
2026-03-31
View
8-KCurrent Report
8-K
2026-03-31
View
8-KCurrent Report
8-K
2026-03-30
View
3Initial Statement of Beneficial Ownership
3
2026-03-18
View
3Initial Statement of Beneficial Ownership
FORM 3
2026-03-16
View
3Initial Statement of Beneficial Ownership
FORM 3
2026-03-16
View
3Initial Statement of Beneficial Ownership
FORM 3
2026-03-16
View
Showing 1–15 of 165 filingsForm 4 / 144 hidden· 182 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001835268  |  Exchange: NASDAQ · Healthcare

Connect Biopharma Holdings Limited (NASDAQ: CNTB) has submitted 182 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Healthcare sector company with CIK 0001835268, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Connect Biopharma Holdings Limited's most comprehensive regulatory disclosure. The most recent Connect Biopharma Holdings Limited 10-K was filed on 2026-03-31 for fiscal year ending 2026. Historical CNTB 10-K annual reports are available from 2020 through 2026.

Investors researching Connect Biopharma Holdings Limited SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
OVID SEC Filings →STRO SEC Filings →STTK SEC Filings →ARTV SEC Filings →CNTX SEC Filings →IFRX SEC Filings →KLRS SEC Filings →IMA SEC Filings →
→ CNTB Financials→ CNTB Earnings→ CNTB Insider Trades

Frequently Asked Questions

CNTB SEC Filings · 8 questions

Connect Biopharma Holdings Limited (CNTB) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 182 filings and access original documents at no cost. Connect Biopharma Holdings Limited's CIK is 0001835268.

CNTB SEC filingsConnect Biopharma Holdings Limited SEC documentsfind CNTB 10-K